Device manufacturer, as written on reports
Biotronik Se & Kg: medical device reports filed with FDA
76,593 reports name it as the manufacturer of the device involved, 2009–2026.
- 76,593
- reports naming it as manufacturer
- 0.3% of all MAUDE reports
- 6,233
- reports, 12 months to August 2026
- 6,204 in the 12 months before
- 56.7%
- classified as malfunction
- 62.3% across all reports
- 0.9%
- classified as death, as reported
- 0.9% across all reports
76,593 medical device reports received by FDA give Biotronik Se & Kg as the manufacturer of the device involved, 0.3% of the MAUDE database, from July 2009 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
6,233 reports arrived in the 12 months to August 2026, close to the 6,204 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (56.7%), injury (41.9%) and death (0.9%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Solia S 53 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 4,993 | 647 | 0.5% |
| Dextrus 4136 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 4,910 | 0 | 0.8% |
| Setrox S 53 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 3,309 | 128 | 1.2% |
| Solia S 60 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 2,637 | 495 | 0.5% |
| Plexa ProMRI S 65 | Permanent defibrillator electrodes | 2,519 | 245 | 0.6% |
| Dextrus 4135 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 2,298 | 0 | 0.5% |
| Solia S 45 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 2,021 | 241 | 0.5% |
| Dextrus 4137 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 2,017 | 0 | 1% |
| Dextrus 53 Model 4136 US 644136-102 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 1,821 | 155 | 0.4% |
| Sentus ProMRI OTW QP L-85/49 | Drug eluting permanent left ventricular (lv) pacemaker electrode | 1,684 | 249 | 0.5% |
| Linox Smart S DX 65/15 | Permanent defibrillator electrodes | 1,184 | 113 | 0.5% |
| Protego ProMRI S 65 | Permanent defibrillator electrodes | 1,088 | 76 | 0.6% |
| Setrox S 60 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 1,052 | 43 | 0.6% |
| Setrox S 45 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 986 | 35 | 1.3% |
| Linox SD 65/16 | Permanent defibrillator electrodes | 969 | 31 | 1.2% |
| Linox S 65 | Permanent defibrillator electrodes | 901 | 25 | 0.6% |
| Plexa ProMRI S DX 65/15 | Permanent defibrillator electrodes | 889 | 130 | 0.1% |
| Dextrus 60 Model 4137 US 644137-102 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 860 | 49 | 0.5% |
| Dextrus 45 Model 4135 US 644135-102 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 831 | 82 | 0.4% |
| Plexa ProMRI DF-1 S DX 65/15 | Permanent defibrillator electrodes | 820 | 93 | 0% |
| Linox SD 65/18 | Permanent defibrillator electrodes | 792 | 24 | 1.1% |
| Protego S 65 | Permanent defibrillator electrodes | 619 | 44 | 1.2% |
| Linox Smart S 65 | Permanent defibrillator electrodes | 618 | 26 | 0.7% |
| Linox Smart S DX 65/17 | Permanent defibrillator electrodes | 614 | 45 | 0.2% |
| Sentus ProMRI OTW QP S-85/49 | Drug eluting permanent left ventricular (lv) pacemaker electrode | 609 | 50 | 0.2% |
| Acticor 7 VR-T DX DF4 ProMRI | Implantable cardioverter defibrillator (non-crt) | 582 | 180 | 1% |
| Linox Smart ProMRI S 65 | Permanent defibrillator electrodes | 534 | 20 | 0.2% |
| Selox ST 53 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 533 | 16 | 0.7% |
| Linox Smart SD 65/18 | Permanent defibrillator electrodes | 532 | 22 | 0.4% |
| BIOMONITOR IIIm | Recorder, event, implantable cardiac, (with arrhythmia detection) | 391 | 66 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| NVN | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 26,700 | 34.9% |
| NVY | Permanent defibrillator electrodes | 18,984 | 24.8% |
| LWS | Implantable cardioverter defibrillator (non-crt) | 7,950 | 10.4% |
| NVZ | Pulse generator, permanent, implantable | 7,245 | 9.5% |
| MRM | Defibrillator, implantable, dual-chamber | 4,151 | 5.4% |
| OJX | Drug eluting permanent left ventricular (lv) pacemaker electrode | 3,939 | 5.1% |
| NIK | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 2,651 | 3.5% |
| DTB | Permanent pacemaker electrode | 2,100 | 2.7% |
| MXD | Recorder, event, implantable cardiac, (with arrhythmia detection) | 1,486 | 1.9% |
| NKE | Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p) | 611 | 0.8% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Biotronik Se & Kg reports
How many FDA device reports name Biotronik Se & Kg as manufacturer?
76,593 reports through August 2026, 6,233 of them in the latest 12 months.
Which of its brands appear most often?
Solia S 53 (4,993), Dextrus 4136 (4,910), Setrox S 53 (3,309), Solia S 60 (2,637) and Plexa ProMRI S 65 (2,519).
Which device types does it report on?
drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes (34.9%), permanent defibrillator electrodes (24.8%), implantable cardioverter defibrillator (non-crt) (10.4%) and pulse generator, permanent, implantable (9.5%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.